1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Leukopenia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 17 (60.71) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brito, GA; Cunha, FQ; Justino, PF; Lima-Junior, RC; Mota, JM; Ribeiro, RA; Soares, PM; Souza, MH | 1 |
| De Plaen, IG; Han, XB; Hsueh, W; Liu, X | 1 |
| Demopoulos, CA; Kapoulas, VM; Tsabikakis, GE | 1 |
| Hirayama, K; Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
| Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
| Arreto, CD; Bureau, MF; Imaizumi, A; Vargaftig, BB | 1 |
| Barbosa-Filho, JM; Castro-Faria-Neto, HC; Cordeiro, RS; Herbert, JM; Tibiriça, E | 1 |
| LeClerc, JL; Vincent, JL; Wan, S | 1 |
| Costa, JJ; Delano, FA; Harris, AG; Schmid-Schönbein, GW; Zweifach, BW | 1 |
| Arnoux, B; Canaud, B; Chavis, C; Cristol, JP; Damon, M; Mion, C | 1 |
| Durán, WN; Egan, RW; Tomeo, AC | 1 |
| Bernat, A; Gigo, V; Herbert, JM; Lale, A; LaPlace, MC; Le Fur, G; Lespy, L; Maffrand, JP; Savi, P; Valette, G | 1 |
| Coyle, AJ; Lefort, J; Vargaftig, BB | 1 |
| Fenton, J; Gudewicz, PW; Kaplan, JE; Moon, DG; van der Zee, H | 1 |
| Hsueh, W; Zhang, C | 1 |
| Agrawal, DK; Bewtra, AK; Hopp, RJ; Townley, RG | 1 |
| Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R | 1 |
| Lefort, J; Lellouch-Tubiana, A; Terlain, B; Vannier, E; Vargaftig, BB | 1 |
| Halonen, M; Lohman, I | 1 |
| Farhat, M; Feuerstein, G; Perera, PY; Rabinovici, R; Vogel, SN; Yue, TL | 1 |
| Hsueh, W; Sun, XM | 1 |
| Braquet, P; Lejeune, V; Mencia-Huerta, JM; Touvay, C; Vilain, B | 1 |
| Davis, D; Fowler, AA; Glauser, FL; Sessler, CN | 1 |
| Wallace, JL; Whittle, BJ | 1 |
| Angle, MJ; McManus, LM; Pinckard, RN; Showell, HJ | 1 |
| Lefort, J; Malanchère, E; Pretolani, M; Vargaftig, BB | 1 |
| Aoki, H; Kohsaka, M; Nishikawa, M; Okamoto, M; Yoshida, K | 1 |
| Biftu, T; Doebber, TW; Wu, MS | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukopenia
| Article | Year |
|---|---|
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
Topics: Adrenal Cortex Hormones; Anticoagulants; Antioxidants; Aprotinin; Arachidonic Acids; Cardiopulmonary Bypass; Cell Adhesion Molecules; Complement Activation; Cytokines; Endothelins; Endotoxins; Equipment Design; Free Radicals; Gene Expression; Heparin; Humans; Inflammation; Inflammation Mediators; Leukocytes; Leukopenia; Nitric Oxide; Platelet Activating Factor; Reactive Oxygen Species; Serine Proteinase Inhibitors; Systemic Inflammatory Response Syndrome; Ultrafiltration | 1997 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukopenia
| Article | Year |
|---|---|
Platelet-activating factor production during hemodialysis: effect of BN 52021.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Amyloidosis; beta 2-Microglobulin; Biocompatible Materials; Blood Platelets; Calcimycin; Cellulose; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Hydroxyeicosatetraenoic Acids; Lactones; Leukopenia; Lipoxygenase; Lymphocyte Activation; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Activation; Random Allocation; Renal Dialysis | 1992 |
Terfenadine effect on the bronchoconstriction, dermal response, and leukopenia induced by platelet-activating factor.
Topics: Asthma; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Histamine; Humans; Leukopenia; Male; Platelet Activating Factor; Skin Tests; Terfenadine; Time Factors | 1991 |
25 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukopenia
| Article | Year |
|---|---|
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Cytokines; Duodenum; Fluorouracil; Ginkgolides; Intestinal Diseases; Intestinal Mucosa; Lactones; Leukocyte Count; Leukopenia; Mice; Mice, Inbred BALB C; Mice, Knockout; Mucositis; Peroxidase; Platelet Activating Factor; Receptors, Platelet-Derived Growth Factor | 2011 |
Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor.
Topics: Animals; Antibodies, Blocking; Chemokine CXCL2; Chemokines; Chemokines, CXC; Gene Expression Regulation; Hematocrit; Hypotension; Ileum; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Leukopenia; Male; Monokines; Neutrophil Infiltration; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs.
Topics: Anaphylaxis; Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Infusions, Parenteral; Leukocyte Count; Leukopenia; Lysophosphatidylcholines; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia | 1981 |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Cells; Blood Pressure; Cardiac Output; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypotension; Indomethacin; Injections, Intravenous; Leukopenia; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Starfish; Tachyphylaxis; Thrombocytopenia; Vascular Resistance; Venoms | 1994 |
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Biological Assay; Creatine Kinase; Isoenzymes; Leukopenia; Macrophages; Male; Myocardial Ischemia; Myocardial Reperfusion; Necrosis; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 1993 |
Pharmacological differentiation by pertussis toxin of the in vivo acute responses to fMLP and PAF in guinea-pig lungs.
Topics: Acetylcholine; Animals; Blood Platelets; Blood Volume; Bronchoconstriction; Capillary Permeability; Female; Guinea Pigs; Leukocytes; Leukopenia; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Pertussis Toxin; Platelet Activating Factor; Thrombocytopenia; Virulence Factors, Bordetella | 1993 |
Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin.
Topics: Animals; Blood Platelets; Furans; Guinea Pigs; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes; Leukopenia; Lignans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Thiazoles; Thrombocytopenia; Tumor Necrosis Factor-alpha | 1997 |
Mechanisms of cell injury in rat mesentery and cremaster muscle.
Topics: Abdomen; Animals; Cell Adhesion; Endothelium, Vascular; Inflammation; Leukocyte Count; Leukopenia; Mesentery; Muscles; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Rats; Rats, Wistar; Reactive Oxygen Species; Time Factors | 1998 |
Priming interactions between platelet activating factor and histamine in the in vivo microcirculation.
Topics: Animals; Cricetinae; Histamine; Histamine Antagonists; Leukopenia; Leukotrienes; Male; Mesocricetus; Microcirculation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1991 |
Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Topics: Animals; Azepines; Blood Platelets; Bronchoconstriction; Guinea Pigs; Humans; Injections, Intravenous; Leukopenia; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thrombocytopenia; Triazoles | 1991 |
The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.
Topics: Animals; Benzeneacetamides; Benzhydryl Compounds; Blood Platelets; Cetirizine; Female; Guinea Pigs; Histamine H1 Antagonists; Hydroxamic Acids; Hydroxyzine; In Vitro Techniques; Leukocyte Count; Leukopenia; Leukotriene B4; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Pyrilamine; Terfenadine | 1991 |
Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
Topics: Animals; Azepines; Carbon Dioxide; Cell Adhesion; Leukocyte Count; Leukopenia; Platelet Activating Factor; Sheep; Thrombin; Thrombocytopenia; Thromboxane B2; Triazoles | 1991 |
PAF-induced bowel necrosis. Effects of vasodilators.
Topics: Alprostadil; Animals; Hydralazine; Hypotension; Indazoles; Intestinal Diseases; Leukopenia; Male; Mesenteric Arteries; Necrosis; Nitroglycerin; Phenoxybenzamine; Platelet Activating Factor; Prazosin; Rats; Rats, Inbred Strains; SRS-A; Vasodilator Agents | 1991 |
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.
Topics: Animals; Antigens; Aspirin; Bronchoconstriction; Cell Degranulation; Endotoxins; Escherichia coli; Guinea Pigs; Hemodynamics; Histamine; Hypersensitivity; Leukopenia; Lipopolysaccharides; Mast Cells; Microscopy, Electron; N-Formylmethionine Leucyl-Phenylalanine; Ovalbumin; Platelet Activating Factor; Pyrilamine; Thromboxane B2 | 1991 |
Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
Topics: Anaphylaxis; Animals; Azepines; Bronchial Spasm; Hypotension; Immunoglobulin E; Leukopenia; Lung; Platelet Activating Factor; Rabbits; Thrombocytopenia; Triazoles | 1990 |
Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Topics: Animals; Azepines; Blood Cell Count; Endotoxins; Leukopenia; Male; Platelet Activating Factor; Rabbits; Thrombocytopenia; Thromboxane B2; Triazoles | 1990 |
Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor.
Topics: Animals; Drug Synergism; Intestines; Leukopenia; Lipopolysaccharides; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Recombinant Proteins; Thiazoles; Tumor Necrosis Factor-alpha | 1989 |
Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig.
Topics: Animals; Antigens; Bronchial Provocation Tests; Bronchial Spasm; Cyclosporins; Diterpenes; Ginkgolides; Guinea Pigs; Immunization, Passive; In Vitro Techniques; Lactones; Leukopenia; Male; Platelet Activating Factor; Thrombocytopenia | 1989 |
Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep.
Topics: Animals; Endotoxins; Hemodynamics; Leukopenia; Lymph; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Pulmonary Gas Exchange; Quinolinium Compounds; Sheep; Toxemia | 1988 |
Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.
Topics: Acid Phosphatase; Animals; Colon; Dexamethasone; Erythrocyte Count; Gastric Mucosa; Intestinal Mucosa; Jejunum; Leukopenia; Male; Platelet Activating Factor; Platelet Count; Premedication; Rats; Rats, Inbred Strains | 1988 |
Ontogeny of the responsiveness to intravenous platelet-activating factor.
Topics: Aging; Anaphylaxis; Animals; Animals, Newborn; Female; Leukopenia; Lung; Male; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Rabbits; Thrombocytopenia; Thromboxane B2 | 1987 |
Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Topics: Anaphylaxis; Animals; Azepines; Female; Guinea Pigs; Histamine; In Vitro Techniques; Indicators and Reagents; Leukopenia; Male; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Radioimmunoassay; Respiratory System; Spectrometry, Fluorescence; Thrombocytopenia; Thromboxane B2; Triazines; Triazoles | 1987 |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF.
Topics: Animals; Cell Count; Depression, Chemical; Drug Interactions; Endotoxins; Indoles; Injections, Intravenous; Leukopenia; Male; Piperazines; Platelet Activating Factor; Rabbits; Thrombocytopenia; Time Factors | 1986 |
Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
Topics: Acetylglucosaminidase; Animals; Blood Pressure; Endotoxins; Female; Furans; Hydrolases; Leukopenia; Lysosomes; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1986 |